Stay updated on DPX-Survivac Therapy in Recurrent Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the DPX-Survivac Therapy in Recurrent Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DPX-Survivac Therapy in Recurrent Ovarian Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    - Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-25T20:08:32.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision metadata updated: added Revision: v3.4.3 and removed Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T17:00:17.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Added Fallopian Tube Cancer to the Conditions section and added Genetic and Rare Diseases Information Center to the Resources.
    Difference
    0.2%
    Check dated 2026-02-18T03:43:50.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page shows a minor site maintenance update: a new Revision: v3.4.2 was added and older notices (including the funding lapse notice and Revision: v3.4.1) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T01:46:38.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Added a government funding status notice indicating potential delays and open NIH facilities; updated the page revision to v3.4.1, replacing the previous v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-03T22:33:04.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    The changes are minor UI and metadata updates, including the addition of a glossary toggle and new QC-related fields (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0) and the removal of older QC labels and data references (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T20:44:44.000Z thumbnail image

Stay in the know with updates to DPX-Survivac Therapy in Recurrent Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DPX-Survivac Therapy in Recurrent Ovarian Cancer Clinical Trial page.